Phibro Animal Health Co. (NASDAQ:PAHC - Get Free Report) reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $26.55 and last traded at $26.14, with a volume of 82337 shares changing hands. The stock had previously closed at $25.77.
Wall Street Analysts Forecast Growth
A number of research firms have recently issued reports on PAHC. Barclays lifted their price objective on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a report on Monday, February 10th. StockNews.com downgraded shares of Phibro Animal Health from a "strong-buy" rating to a "buy" rating in a report on Thursday, February 6th. Finally, Morgan Stanley lifted their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a report on Tuesday, December 17th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $21.00.
Get Our Latest Analysis on Phibro Animal Health
Phibro Animal Health Stock Down 2.0 %
The stock has a market capitalization of $911.25 million, a price-to-earnings ratio of 46.88, a PEG ratio of 0.47 and a beta of 0.52. The firm has a 50-day moving average of $22.21 and a 200 day moving average of $22.07. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. As a group, sell-side analysts forecast that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.
Phibro Animal Health Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.13%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health's dividend payout ratio is 100.00%.
Institutional Investors Weigh In On Phibro Animal Health
Several hedge funds have recently added to or reduced their stakes in PAHC. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Phibro Animal Health during the 4th quarter valued at $29,000. Lazard Asset Management LLC lifted its holdings in Phibro Animal Health by 2,739.7% during the 4th quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock valued at $34,000 after purchasing an additional 1,589 shares during the last quarter. Aquatic Capital Management LLC acquired a new stake in Phibro Animal Health during the 4th quarter valued at $69,000. Virtus Fund Advisers LLC acquired a new position in shares of Phibro Animal Health in the fourth quarter valued at approximately $69,000. Finally, Quantbot Technologies LP acquired a new position in shares of Phibro Animal Health in the third quarter valued at approximately $70,000. Institutional investors and hedge funds own 99.34% of the company's stock.
Phibro Animal Health Company Profile
(
Get Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Recommended Stories
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.